Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up

Preventive Medicine

Volumn 49, Issue 1, 2009, Pages 45-47

  Kunnas, T ^a   Solakivi, T ^a   Huuskonen, K ^a   Kalela, A ^a   Renko, J ^a   Nikkari, Seppo T ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiovascular disease; Coronary heart disease; Hematocrit; Mortality

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY RISK; FINLAND; FOLLOW UP; HEALTH SURVEY; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; POLYCYTHEMIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGED; BIOLOGICAL MARKERS; CAUSE OF DEATH; CORONARY DISEASE; FINLAND; FOLLOW-UP STUDIES; HEALTH SURVEYS; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; POLYCYTHEMIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 67650682104     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2009.04.015     Document Type: Article

References (11)

1. Brown D.W., Giles W.H., and Croft J.B. Hematocrit and the risk of coronary heart disease mortality. Am. Heart J. 142 (2001) 657-663
2. Carter C., McGee D., Reed D., Yano K., and Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am. Heart J. 105 (1983) 674-679
3. Erikssen G., Thaulow E., Sandvik L., Stormorken H., and Erikssen J. Haematocrit: a predictor of cardiovascular mortality?. J. Intern. Med. 234 (1993) 493-499
4. Gagnon D.R., Zhang T.J., Brand F.N., and Kannel W.B. Hematocrit and the risk of cardiovascular disease-the Framingham Study: a 34-year follow-up. Am. Heart J. 127 (1994) 674-682
5. Goubali A., Voukiklaris G., Kritsikis S., Viliotou F., and Stamatis D. Relation of hematocrit values to coronary heart disease, arterial hypertension, and respiratory impairment in occupational and population groups of the Athens area. Angiology 46 (1995) 719-725
6. Karino T., and Goldsmith H.L. Role of blood cell-wall interactions in thrombogenesis and atherogenesis: a microrheological study. Biorheology 21 (1984) 587-601
7. Lloyd-Jones D.M., Dyer A.R., Wang R., Daviglus M.L., and Greenland P. Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am. J. Cardiol. 99 (2007) 535-540
8. Quaknine-Orlando B., Samama C.M., Riou B., et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 90 (1999) 1454-1461
9. Salonen J.T., Tuomainen T.P., Salonen R., Lakka T.A., and Nyyssönen K. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. Am. J. Epidemiol. 148 (1998) 445-451
10. Sorlie P.D., Garcia-Palmieri M.R., Costas Jr. R., and Havlik R.J. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program. Am. Heart J. 101 (1981) 456-461
11. Wu W.C., Schifftner T.L., Henderson W.G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 297 (2007) 2481-2488